A pediatric asthma subgroup at high risk for acute respiratory infections can be identified using 2 natural language processing algorithms.

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...

Children with mild asthma at low risk for severe exacerbations may not need daily or as-needed ICS, as GINA guidelines recommend.

New guidelines that seek to change how asthma is treated in Australia have been unveiled by Health Minister Mark Butler and the National Asthma Council of Australia (NAC).

Discover a study showing budesonide–formoterol cuts childhood asthma attacks by 45%, offering a safer alternative to ...

Among pediatric patients with intermittent asthma, around one-third did not have significant acute care needs over a 2-year ...

The 2018 Lancet Commission,1 After asthma: redefining airways diseases, made clear recommendations to improve outcomes for ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children ...

The National Asthma Council’s advice for treating the condition has been updated, advising doctors against solely prescribing blue puffers to patients.

A joint scientific study conducted by researchers at the Medical Research Institute of New Zealand, in collaboration with ...

M Indians suffer from asthma—13% of global cases. Mortality is far higher than average due to late diagnosis, outdated care, ...